Bioengineered 'External Liver' tested as bridge to recovery
NCT ID NCT06285253
Summary
This early-stage study tested the safety of a temporary, external bioengineered liver device called miroliverELAP. It was used for up to 48 hours in 10 critically ill adults with sudden, severe liver failure. The goal was to see if the device could safely support patients' failing livers, giving their own livers time to heal or allowing time to arrange a transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ALCOHOLIC HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Intermountain Healthcare
Salt Lake City, Utah, 84103, United States
-
Mayo Clinic
Rochester, Minnesota, 55902, United States
-
Mount Sinai Recanati/Miller Transplantation Institute
New York, New York, 10029, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
University of Michigan Medical School
Ann Arbor, Michigan, 48109, United States
-
University of Minnesota Medical School
Minneapolis, Minnesota, 55455, United States
-
Virginia Commonwealth University Medical Center
Richmond, Virginia, 23970, United States
Conditions
Explore the condition pages connected to this study.